RYAM

RYAM is a diversified cellulose-specialties and commodity-pulp producer whose numbers describe a business in structural distress, not a cheap turnaround. FY2025 revenue fell 10.1% to $1.47B and the company posted a $421M net loss (diluted EPS -$6.33) — but note operating income was still positive at $4.1M and operating cash flow was positive at $23.9M, so the bulk of that loss is non-cash. That reconciles with the filing: the 140,000 MT Temiscaming cellulose plant was indefinitely suspended in July 2024 and permanently ceased DWP production in Q1 2026, the kind of event that drives large impairment/write-down charges. Even setting the impairment aside, the underlying franchise is weak: gross margin is just 8.1% and operating margin is 0.3%, meaning the company barely breaks even before financing costs in a good scenario.

The track record is the tell. Net income has been negative in four of the last five years (FY2022 -$14.9M, FY2023 -$102M, FY2024 -$38.7M, FY2025 -$421M), with the one profitable year (FY2021, $66.4M) now four years in the rear view. Revenue has drifted down from a $1.72B FY2022 peak. Return on equity is -132.9% and retained earnings have flipped to -$88.9M, while stockholders' equity collapsed 55.7% YoY to $317M. This is a commodity-exposed processor whose specialty pricing is set by annual contracts but whose commodity and pulp segments are indexed to volatile published prices — earnings power is neither durable nor visibly improving.